A news brief published in the Oct. 30, 2002, issue of BioWorld Today on Aeson Therapeutics Inc., of Tucson, Ariz., should have said the company is in the middle of a Phase II trial of fluasterone as a lipid-lowering drug.

Editor's Note: The change had been made in BioWorld Today online.